Objective: To estimate the early and long-term mortalities and associated risk factors in
adults receiving highly active antiretroviral therapy (HAART) in Thailand. Design: A …

Mortality in HIV-infected patients has decreased dramatically since the introduction of highly
active antiretroviral therapy (HAART). We analyzed progression to death in a population of …

Background: The extent to which the prognosis for AIDS and death of patients initiating
highly active antiretroviral therapy (HAART) continues to be affected by their characteristics …

Background: AIDS-related death and disease rates have declined in the highly active
antiretroviral therapy (HAART) era and remain low; however, current causes of death in …

Objectives: To examine survival and progression to AIDS among HIV-infected patients after
starting highly active antiretroviral therapy (HAART). Methods: The study population …

Background: Although HIV treatment guidelines recommend highly active antiretroviral
therapy (HAART) initiation before reaching a CD4 count of 200 cells/mm 3, many people in …

Background: Although nearly 2 million people live with HIV in Latin America and the
Caribbean, mortality rates after initiation of highly active antiretroviral therapy (HAART) have …

Methods: We analyzed cohort data from Zambia to investigate whether 6-and 12-month
CD4+ response after ART initiation was associated with later mortality. We used Cox …

Objective We aimed to examine the clinical outcome in HIV-1-infected patients after more
than 10 years of highly active antiretroviral therapy (HAART). Methods We analyzed data …

Background. The magnitude of the impact of highly active antiretroviral therapy (HAART)
since its introduction in non-Western countries is not entirely clear. We studied disease …